About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 303 record(s)
Req # A-2020-00420
Briefing note 44581448: Interim Directive on Privacy Practices and Interim Directive on Privacy Impact Assessment to address COVID-19-related urgenciesOrganization: Treasury Board of Canada Secretariat
October 2020
Req # A-2020-00435
Copy of the President of the Treasury Board of Canada’s 2019 briefing bookOrganization: Treasury Board of Canada Secretariat
October 2020
Req # A-2020-00438
Briefing note 45566968: Invitation to National Indigenous organizations to participate in the Access to Information Act ReviewOrganization: Treasury Board of Canada Secretariat
October 2020
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-00281
Temporary Help Services Supply Arrangement and Standing Offer callups issued in the National Capital Region from April 1 to June 30, 2020Organization: Treasury Board of Canada Secretariat
September 2020
Req # A-2019-01167
Task Authorization 17-053-TA-005 for 2018 contract between Treasury Board Secretariat Internal Audit and Evaluation Branch and Ernst & YoungOrganization: Treasury Board of Canada Secretariat
September 2020
Req # A-2020-00052
Email Transformation Initiative replacement contract for email and BlackBerry services with Bell Canada from November 1, 2011 to May 20, 2020Organization: Treasury Board of Canada Secretariat
September 2020